5
Techtrek
513153 BSE
Techtrek
Industrials BSE: 513153 Industrial Products
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
1- Stock is trading at 0.18 times its book value
Weaknesses
4- Company has low interest coverage ratio.
- Company has a low return on equity of 0.66% over last 3 years.
- Earnings include an other income of Rs.2.13 Cr.
- Company has high debtors of 1,022 days.
Growth Rate
Revenue Growth
-12%
Net Income Growth
482% higher than
3Y
Quarterly Results
| Particulars | Mar 2013 | Jun 2013 | Sep 2013 | Dec 2013 | Mar 2014 | Jun 2014 |
|---|---|---|---|---|---|---|
| Sales | 0.09 | 0 | -0.08 | 0.08 | 0.23 | 0.65 |
| Expenses | 0.17 | 0.15 | 0.2 | 0.19 | 0.49 | 0.77 |
| Operating Profit | -0.08 | -0.15 | -0.28 | -0.11 | -0.26 | -0.12 |
| OPM % | -88.89% | — | — | -137.5% | -113.04% | -18.46% |
| Other Income | 0.77 | 0.43 | 0.45 | 0.44 | 0.71 | 0.53 |
| Interest | 0.26 | 0.17 | 0.17 | 0.17 | 0.16 | 0.15 |
| Depreciation | 0.06 | 0 | 0.03 | 0.02 | 0.02 | 0.02 |
| PBT | 0.37 | 0.11 | -0.03 | 0.14 | 0.27 | 0.24 |
| Tax % | 18.92% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | 0.31 | 0.11 | -0.03 | 0.14 | 0.27 | 0.25 |
| EPS in Rs | 0.85 | 0.3 | -0.08 | 0.39 | 0.74 | 0.69 |
Profit & Loss
| Particulars | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 0.89 | 1.16 | 0 | 0.77 | 0.17 | 0.15 | 0.88 |
| Expenses | 0.24 | 0.6 | 0.45 | 0.53 | 0.73 | 0.67 | 1.65 |
| Operating Profit | 0.65 | 0.56 | -0.45 | 0.24 | -0.56 | -0.52 | -0.77 |
| OPM % | 73.03% | 48.28% | — | 31.17% | -329.41% | -346.67% | -87.5% |
| Other Income | 0.12 | 0.33 | 1.34 | 0.13 | 1.06 | 1.81 | 2.13 |
| Interest | 0.15 | 0.14 | 0 | 0.31 | 0.32 | 0.8 | 0.65 |
| Depreciation | 0.06 | 0.04 | 0.04 | 0.04 | 0.06 | 0.06 | 0.09 |
| PBT | 0.56 | 0.71 | 0.85 | 0.02 | 0.12 | 0.43 | 0.62 |
| Tax % | 30.36% | 23.94% | 23.53% | 150% | 225% | 16.28% | — |
| Net Profit | 0.39 | 0.54 | 0.65 | -0.01 | -0.15 | 0.37 | 0.63 |
| EPS in Rs | 1.07 | 1.49 | 1.79 | -0.03 | -0.41 | 1.02 | 1.74 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 3.63 | 3.63 | 3.63 | 3.63 | 3.63 | 3.63 | 3.63 |
| Reserves | 10.53 | 11.07 | 11.72 | 11.71 | 11.57 | 10.62 | 10.8 |
| Borrowings | 2.39 | 1.7 | 2.63 | 3.86 | 3.75 | 5.46 | 5.87 |
| Other Liabilities | 1.75 | 4.35 | 3.59 | 3.48 | 4.01 | 3.26 | 3.43 |
| Total Liabilities | 18.3 | 20.75 | 21.57 | 22.68 | 22.96 | 22.97 | 23.73 |
| Fixed Assets | 15.97 | 15.94 | 17.79 | 18.96 | 19.37 | 18.19 | 17.97 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 2.33 | 4.81 | 3.78 | 3.72 | 3.59 | 4.78 | 5.76 |
| Total Assets | 18.3 | 20.75 | 21.57 | 22.68 | 22.96 | 22.97 | 23.73 |
Cash Flow
| Particulars | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 |
|---|---|---|---|---|---|---|
| Operating | — | — | — | 0.24 | 1.6 | -0.4 |
| Investing | — | — | — | -1.21 | -0.52 | -0.19 |
| Financing | — | — | — | -0.86 | -0.63 | 0.86 |
| Net Cash Flow | — | — | — | -1.83 | 0.45 | 0.27 |
| Free Cash Flow | — | — | — | -0.97 | 1.08 | -0.59 |
| CFO/OP | — | — | — | 100 | -289 | 77 |
Ratios
| Particulars | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 |
|---|---|---|---|---|---|---|
| Debtor Days | 4.1 | 3.15 | — | 142 | 193 | 1,022 |
| Cash Conversion Cycle | 4.1 | 3.15 | — | 142 | 193 | 1,022 |
| Working Capital Days | 115 | -211 | — | -1,725 | -9,061 | -7,057 |
| ROCE % | — | 5.16% | 4.94% | 1.78% | 2.57% | 6.67% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Techtrek insights
50 extracted metrics + investor summaries across FY08–FY26.
Documents
1
Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Incorporation Of Subsidiary
7h - Incorporated Alembic Pharmaceuticals (Thailand) Co., Ltd on Mar 9, 2026; share capital Baht 3,000,000; Alembic holds 99.99%. 7h - Incorporated Alembic Pharmaceuticals (Thailand) Co., Ltd on Mar 9, 2026; share capital Baht 3,000,000; Alembic holds 99.99%.
2
Announcement under Regulation 30 (LODR)-Press Release / Media Release
10h - 6 Mar 2026: Alembic reports first US prescription sale of Pivya (pivmecillinam) after commercial launch. 10h - 6 Mar 2026: Alembic reports first US prescription sale of Pivya (pivmecillinam) after commercial launch.
3
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
7h - One-on-one meeting with Bajaj Finserv AMC on 11 March 2026 in Vadodara. 7h - One-on-one meeting with Bajaj Finserv AMC on 11 March 2026 in Vadodara.
4
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
13h - Management meeting with HDFC MF, TATA AIA, HDFC Life, Birla Life, ICICI Prudential on 6 March 2026 in Mumbai. 13h - Management meeting with HDFC MF, TATA AIA, HDFC Life, Birla Life, ICICI Prudential on 6 March 2026 in Mumbai.
Frequently Asked Questions about Techtrek
What does Techtrek India Ltd do?
Techtrek India Limited, incorporated in India, Listed on the Bombay Stock exchange Limited, the company is engaged in a global consulting and IT Services provider company.
Where is Techtrek India Ltd (513153) listed?
Techtrek India Ltd trades under code 513153 on the BSE.
Which sector does Techtrek India Ltd belong to?
Techtrek India Ltd is classified under the Industrials sector, in the Industrial Products industry.
Company Information
Techtrek India Limited, incorporated in India, Listed on the Bombay Stock exchange Limited, the company is engaged in a global consulting and IT Services provider company.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/513153.md for Techtrek India Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.